Call for more patient-centered drug development in oncology — NEJM

In an article in the New England Journal of Medicine (NEJM), published online on 3 July 2013, Dr Ethan Basch highlights the lack of information on how a drug will make patients feel in the US label of most new cancer drugs.  … Continue reading

Pharma’s return to growth: EvaluatePharma

On 26 June, EvaluatePharma released their “World Preview: 2013” report which forecasts a return to return to growth of the global biopharma market – in contrast to their prediction of unprecedented market contraction in the 2012 report.  It seems that we … Continue reading

US hospital says “no” to spiralling price of oncology drugs

In an op-ed in the New York Times on 14 September 2012, Memorial Sloan-Kettering Cancer Center published the rationale for their decision not to give Sanofi and Regeneron’s new drug, Zaltrap, to their patients with colorectal cancer. The authors cite … Continue reading